Viewing Study NCT01177735


Ignite Creation Date: 2025-12-24 @ 10:06 PM
Ignite Modification Date: 2025-12-29 @ 3:41 PM
Study NCT ID: NCT01177735
Status: COMPLETED
Last Update Posted: 2021-04-22
First Post: 2010-05-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myeloma
Sponsor: University of Arkansas
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-10
Start Date Type: None
Primary Completion Date: 2013-09
Primary Completion Date Type: ACTUAL
Completion Date: 2013-09
Completion Date Type: ACTUAL
First Submit Date: 2010-05-14
First Submit QC Date: None
Study First Post Date: 2010-08-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-11-25
Results First Submit QC Date: None
Results First Post Date: 2015-03-04
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-03-30
Last Update Post Date: 2021-04-22
Last Update Post Date Type: ACTUAL